Boosting regional integration for COP D care through guided implementation and audit of post exacerbation transition bundle - BRIDGE-COPD

Study identifier:D5980L00025

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

Boosting Regional Integration for COPD care through Guided implementation and audit of post exacerbation transition bundle: A multicentre , prospective, cluster randomization, inteventional clinical study

Medical condition

COPD

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

1368

Study type

Observational

Age

40 Years - 80 Years

Date

Study Start Date: 30 Nov 2024
Estimated Primary Completion Date: 31 Aug 2026
Estimated Study Completion Date: 31 Aug 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria